Moran Wealth Management LLC Has $22.79 Million Stock Position in Chemed Co. (NYSE:CHE)

Moran Wealth Management LLC grew its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 13.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 38,975 shares of the company's stock after buying an additional 4,735 shares during the period. Chemed accounts for 0.8% of Moran Wealth Management LLC's investment portfolio, making the stock its 25th biggest position. Moran Wealth Management LLC owned approximately 0.26% of Chemed worth $22,791,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently made changes to their positions in CHE. Massachusetts Financial Services Co. MA raised its holdings in Chemed by 121.5% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 203,096 shares of the company's stock valued at $118,760,000 after acquiring an additional 111,399 shares during the last quarter. International Assets Investment Management LLC acquired a new position in shares of Chemed during the 4th quarter valued at about $430,970,000. Victory Capital Management Inc. increased its stake in shares of Chemed by 19.7% during the 4th quarter. Victory Capital Management Inc. now owns 188,679 shares of the company's stock valued at $110,330,000 after acquiring an additional 31,036 shares during the last quarter. FMR LLC boosted its position in shares of Chemed by 15.4% in the third quarter. FMR LLC now owns 214,994 shares of the company's stock worth $111,732,000 after acquiring an additional 28,682 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its position in shares of Chemed by 9.2% in the third quarter. JPMorgan Chase & Co. now owns 287,386 shares of the company's stock worth $149,355,000 after acquiring an additional 24,161 shares during the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, VP Brian C. Judkins sold 11,158 shares of the business's stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $645.00, for a total value of $7,196,910.00. Following the transaction, the vice president now owns 1,422 shares in the company, valued at $917,190. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Chemed news, VP Brian C. Judkins sold 11,158 shares of the firm's stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $645.00, for a total transaction of $7,196,910.00. Following the completion of the transaction, the vice president now directly owns 1,422 shares of the company's stock, valued at approximately $917,190. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Spencer S. Lee sold 2,000 shares of the company's stock in a transaction dated Thursday, March 28th. The shares were sold at an average price of $641.65, for a total transaction of $1,283,300.00. Following the completion of the sale, the executive vice president now owns 20,760 shares in the company, valued at approximately $13,320,654. The disclosure for this sale can be found here. Insiders sold 15,808 shares of company stock worth $10,184,531 over the last ninety days. Corporate insiders own 3.32% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. Royal Bank of Canada upped their price objective on Chemed from $604.00 to $712.00 and gave the stock an "outperform" rating in a report on Monday, March 4th. StockNews.com raised Chemed from a "hold" rating to a "buy" rating in a research note on Saturday, May 4th. Finally, Oppenheimer increased their target price on shares of Chemed from $625.00 to $650.00 and gave the stock an "outperform" rating in a research report on Thursday, February 29th.

Chemed Trading Down 0.0 %

Shares of CHE traded down $0.03 during midday trading on Tuesday, reaching $568.76. 54,879 shares of the company were exchanged, compared to its average volume of 81,359. Chemed Co. has a 1-year low of $492.84 and a 1-year high of $654.62. The company has a market cap of $8.61 billion, a price-to-earnings ratio of 30.73, a P/E/G ratio of 2.35 and a beta of 0.46. The stock has a 50-day moving average price of $615.59 and a 200-day moving average price of $596.04.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings results on Wednesday, April 24th. The company reported $4.68 EPS for the quarter, missing the consensus estimate of $5.09 by ($0.41). Chemed had a return on equity of 30.52% and a net margin of 12.36%. The company had revenue of $589.23 million for the quarter, compared to analyst estimates of $587.18 million. Equities research analysts anticipate that Chemed Co. will post 21.72 earnings per share for the current year.

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Monday, February 26th were issued a $0.40 dividend. The ex-dividend date of this dividend was Friday, February 23rd. This represents a $1.60 dividend on an annualized basis and a yield of 0.28%. Chemed's dividend payout ratio is currently 8.61%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.